| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Research Articles
Using laser-scanning microscopy to understand immune cell actions in diabetes.
This press release is an announcement submitted by UCSF Diabetes Center, and was not written by Diabetes Health.
The body's immune system is supposed to "tolerate" itself and distinguish "self" from "non-self." Autoimmune diseases such as type 1 diabetes result from the breakdown of this system, causing immune cells to attack and destroy insulin-producing beta cells or "self." In the November issue of Nature Immunology, Brian Fife, PhD and collaborators including senior author Jeffrey Bluestone, PhD share how they have uncovered a basic process that helps control immune cell activation and tolerance.
By utilizing two-photon laser-scanner microscopy to look at individual immune cells in a mouse model of type 1 diabetes, they discovered that when a molecule found on the immune cell called Programmed death 1 (PD-1) binds to another molecule found on another cell, PD-L1, the cells are prevented from forming stable interactions and have increased movement. These fast-moving cells interact less with the cells in the pancreas, thereby preventing type 1 diabetes.
The team hopes that this research will help in the development of a new generation of tolerogenic drugs that will "turn off" selected parts of the immune system, leaving the disease-fighting capabilities intact. A UCSF postdoctoral fellow for six years, Dr. Fife is now a faculty member with the University of Minnesota's Center for Immunology.
* * *
UCSF Diabetes Center e-Update
Categories: Research, Type 1 Issues
0 comments -
Nov 17, 2009 -
Email to a Friend
Send a link to this page to your friends and colleagues.